Protagenic Therapeutics, Inc.\new (PTIX): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report this line under the concept TickerFacts maps.
$671.1K
As of 2020-12-31
+18.9%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2020-12-31 | $671.1K | -16.0% | 2021-03-25, Balance as of period end |
| 2019-12-31 | $798.6K | +120.3% | 2021-03-25, Balance as of period end |
| 2018-12-31 | $362.5K | -9.3% | 2020-04-29, Balance as of period end |
| 2017-12-31 | $399.7K | -87.1% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $3.10M | n/m | 2018-04-02, Balance as of period end |
| 2015-12-31 | $3.3K | n/a | 2017-05-08, Balance as of period end |
| 2015-06-30 | $62.0K | -38.6% | 2015-09-25, Balance as of period end |
| 2014-06-30 | $101.0K | n/a | 2015-09-25, Balance as of period end |